BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26874268)

  • 1. GH response to intravenous clonidine challenge correlates with history of childhood trauma in personality disorder.
    Lee RJ; Fanning JR; Coccaro EF
    J Psychiatr Res; 2016 May; 76():38-43. PubMed ID: 26874268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone responses to intravenous clonidine challenge correlate with behavioral irritability in psychiatric patients and healthy volunteers.
    Coccaro EF; Lawrence T; Trestman R; Gabriel S; Klar HM; Siever LJ
    Psychiatry Res; 1991 Nov; 39(2):129-39. PubMed ID: 1665918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine challenge in childhood anxiety disorder.
    Sallee FR; Richman H; Sethuraman G; Dougherty D; Sine L; Altman-Hamamdzic S
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):655-62. PubMed ID: 9628086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GH response to intravenous clonidine challenge: absence of relationship with behavioral irritability, aggression, or impulsivity in human subjects.
    Coccaro EF; Kavoussi RJ
    Psychiatry Res; 2010 Jul; 178(2):443-5. PubMed ID: 20483477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW; Tancer ME; Rubinow DR; Roscow DB; Boulenger JP; Vittone B; Gurguis G; Geraci M; Black B; Post RM
    Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function.
    Cameron OG; Abelson JL; Young EA
    Biol Psychiatry; 2004 Dec; 56(11):875-83. PubMed ID: 15576065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Biol Psychiatry; 1995 Sep; 38(5):325-9. PubMed ID: 7495927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone responses to GABAB receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects.
    Lee R; Chong B; Coccaro E
    Psychopharmacology (Berl); 2011 May; 215(1):41-8. PubMed ID: 21181128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory tests of growth hormone secretion in prepubertal major depression: depressed versus normal children.
    Ryan ND; Dahl RE; Birmaher B; Williamson DE; Iyengar S; Nelson B; Puig-Antich J; Perel JM
    J Am Acad Child Adolesc Psychiatry; 1994; 33(6):824-33. PubMed ID: 8083139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Arch Gen Psychiatry; 1991 Feb; 48(2):157-62. PubMed ID: 1989571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls.
    Siever LJ; Uhde TW; Silberman EK; Jimerson DC; Aloi JA; Post RM; Murphy DL
    Psychiatry Res; 1982 Apr; 6(2):171-83. PubMed ID: 6283576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD; Papp LA; Martinez J; Pine D; Rosenblum LA; Cooper T; Liebowitz MR; Gorman JM
    Am J Psychiatry; 1995 Apr; 152(4):619-22. PubMed ID: 7694915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Biol Psychiatry; 1992 Jul; 32(1):18-25. PubMed ID: 1391293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone response to growth hormone-releasing hormone and clonidine in young monkeys: correlation with behavioral characteristics.
    Coleman K; Dahl RE; Ryan ND; Cameron JL
    J Child Adolesc Psychopharmacol; 2003; 13(3):227-41. PubMed ID: 14642012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine.
    Coplan JD; Pine DS; Papp LA; Gorman JM
    Psychopharmacol Bull; 1997; 33(2):193-204. PubMed ID: 9230631
    [No Abstract]   [Full Text] [Related]  

  • 20. Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder.
    Tancer ME; Stein MB; Black B; Uhde TW
    Am J Psychiatry; 1993 Feb; 150(2):336-7. PubMed ID: 8422091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.